A randomized clinical trial of symbiotic treatment before surgery for locally recurrent rectal cancer

A randomized clinical trial of symbiotic treatment before surgery for locally recurrent rectal cancer - A randomized clinical trial of symbiotic treatment before surgery for locally recurrent rectal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000041763

Enrollment

Registered

2020-09-14

Start date

2008-06-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

locally recurrent rectal cancer

Interventions

Biolactis powder containing living Lactobacillus casei strain Shirota, BBG01 containing living Bifidobacterium breve strain Yakult, and galactooligosaccharides were administered. Dosage Biolactic po

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with locally recurrent rectal cancer. Patients who are going to receive pre-operative chemoradiation therapy and surgery. Patients who agreed the participation of this study.

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

Measure	Time frame
incidence of surgical site infection after surgery	—

Secondary

Measure	Time frame
The effect of preventing adverse event in pre-operative chemoradiation therapy. The influences in immunological ability caused by pre-operative chemoradiation therapy.	—

Countries

Japan

Contacts

Public ContactMamoru Uemura

Graduate School of Medicine, Osaka University Department of Gastroenterological Surgery

uemura7777@hotmail.com06-6879-3251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026